secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monopar Therapeutics (MNPR)
CIK:        0001645469
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0001437749-25-004910
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Monopar board: Michael Brown resigns, Lavina Talukdar appointed
---------------------------------------------------------------

- Michael J. Brown resigned from the Board effective February 19, 2025.
- Lavina Talukdar appointed to the Board effective February 21, 2025.
- Talukdar also named to Audit, Compensation, Governance, and Plan Administration Committees.
- Talukdar is SVP, Head of Investor Relations at Moderna, with 20+ years of experience.
- She will receive standard compensation for non-employee directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645469/000143774925004910/0001437749-25-004910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645469/000143774925004910/mnpr20250221_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-004910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer